Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

Home

Ruchika Sharma

Articles By : Ruchika Sharma

Adverse drug reactions from normal saline: Punjab imposes 3-year ban on Captab Biotech

156 FDCs banned with immediate effect, declared irrational: Ministry of Health and Family Welfare

Ruchika Sharma22 Aug 2024 6:00 PM IST

New Delhi: Citing that there is no therapeutic justification for the ingredients contained in fixed dose combinations (FDC) and that the FDC may...

Bristol Myers Squibb, SystImmune gets USFDA Breakthrough Therapy Designation for izalontamab brengitecan for previously treated Advanced EGFR Mutated Non Small Cell Lung Cancer

USFDA accepts application for Opdivo plus Yervoy for unresectable hepatocellular carcinoma

Ruchika Sharma22 Aug 2024 4:30 PM IST

Princeton: Bristol Myers Squibb has announced that the U.S. Food and Drug Administration (FDA) has accepted the supplemental Biologics License...

Pune Pharmacist Loses Rs 95 Lakh in Medical Store Deal

Marksans Pharma subsidiary Relonchem bags marketing authorization from UK MHRA for Fluoxetine Capsules

Ruchika Sharma22 Aug 2024 3:25 PM IST

Mumbai: Marksans Pharma Limited has announced that its wholly owned subsidiary Relonchem Limited has received Marketing Authorization from...

Working on Monkeypox vaccine: Serum Institute CEO

Ruchika Sharma22 Aug 2024 1:30 PM IST

New Delhi: The Serum Institute of India has said that the Company is currently working on developing a Monkeypox vaccine to address the...

USFDA approves Tonix Pharma Tonmya for fibromyalgia in adults

Indoco Remedies secures USFDA nod for Lofexidine Tablets 0.18 mg

Ruchika Sharma22 Aug 2024 12:30 PM IST

Mumbai: Indoco Remedies Limited has announced the receipt of final approval from the U.S. Food and Drug Administration (USFDA) for Abbreviated...

Principal Scientific Adviser to GoI reviews progress to transform India regulatory ecosystem for medical products

Ruchika Sharma22 Aug 2024 11:30 AM IST

New Delhi: Prof. Ajay Kumar Sood, Principal Scientific Adviser (PSA) to the Government of India took a meeting to review the progress made...

Daiichi Sankyo, AstraZeneca Enhertu gets USFDA breakthrough therapy designation for certain patients with HER2 low or HER2 ultralow metastatic breast cancer

Ruchika Sharma21 Aug 2024 3:37 PM IST

Tokyo: ENHERTU (fam-trastuzumab deruxtecan-nxki) has been granted Breakthrough Therapy Designation (BTD) in the U.S. for the treatment of unresectable...

AbbVie seeks USFDA nod for combination regimen of Venclexta, Acalabrutinib

JnJ chemotherapy free lung cancer treatment Rybrevant plus Lazcluze gets USFDA okay

Ruchika Sharma21 Aug 2024 12:30 PM IST

New Jersey: Johnson & Johnson has announced that the U.S. Food and Drug Administration (FDA) has approved RYBREVANT (amivantamab-vmjw) plus...

CDSCO Panel Approves GSKs Proposal to Double Indian Patient Pool in Dostarlimab Trial

GSK secures USFDA Breakthrough Therapy Designation for GSK5764227 for extensive stage small cell lung cancer

Ruchika Sharma21 Aug 2024 11:30 AM IST

London: GSK plc has announced that the US Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation for GSK5764227 (GSK’227),...

Darzalex receives positive EMA Committee opinion for high-risk smouldering multiple myeloma: Janssen-Cilag International

Johnson & Johnson to acquire V-Wave

Ruchika Sharma21 Aug 2024 10:00 AM IST

New Brunswick: Johnson & Johnson has announced that it has entered into a definitive agreement to acquire V-Wave Ltd., a privately-held...

Marksans Pharma gets USFDA nod for heartburn drug

USFDA issues EIR for Marksans Pharma Goa facility

Ruchika Sharma20 Aug 2024 4:45 PM IST

Mumbai: Marksans Pharma has announced that the US Food and Drug Administration (USFDA) has issued an Establishment Inspection Report (EIR) for...

Alembic Pharma wins USFDA approval for pulmonary arterial hypertension drug Macitentan

Granules India bags USFDA okay for Glycopyrrolate Oral Solution

Ruchika Sharma20 Aug 2024 3:39 PM IST

Hyderabad: Granules India has announced that the U.S. Food and Drug Administration (FDA) has approved its Abbreviated New Drug Application (ANDA)...

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok